What Is Paraneoplastic Cerebellar Degeneration?

Paraneoplastic cerebellar degeneration is a rare neurological disorder that occurs when a malignancy elsewhere in the body triggers an immune response that mistakenly attacks normal tissue in the cerebellum. The term paraneoplastic refers to conditions that arise as an indirect effect of cancer, rather than from the tumor itself or from metastasis. This disorder is characterized by progressive degeneration of cerebellar neurons, leading to significant impairment of motor coordination and balance.

How the Disorder Develops

In an attempt to fight a tumor, the immune system may produce antibodies that cross-react with antigens expressed by both the cancer cells and the cerebellum. These antibodies and immune effector cells target Purkinje cells, which are large neurons in the cerebellar cortex. The resulting damage leads to irreversible degeneration of the neural tissue. This process generally evolves over weeks or months, and patients may lose substantial motor function before a diagnosis is established.

Symptoms and Clinical Features

The onset of paraneoplastic cerebellar degeneration is often rapid. Early symptoms frequently include a sense of imbalance and dizziness, which many patients initially describe as a feeling of unsteadiness or lightheadedness. However, this is not typically a purely vestibular type of vertigo. While vertigo arises from dysfunction of the inner ear or vestibular nerve, the unsteadiness seen in paraneoplastic cerebellar degeneration stems from impaired coordination in the cerebellum.

As the condition progresses, patients develop:

• Gait ataxia, causing a wide-based, unsteady walk
• Limb incoordination, affecting fine motor tasks such as writing or buttoning a shirt
• Slurred speech, known as dysarthria
• Nystagmus, which is an involuntary rhythmic oscillation of the eyes
• Dysphagia, or difficulty swallowing
• Dizziness and a persistent sense of disequilibrium that worsens with head or body movement

It is important to distinguish vestibular symptoms from pure cerebellar symptoms. Many patients report dizziness as a global feeling of instability rather than rotational vertigo. However, because the cerebellum integrates signals from the vestibular system and other sensory pathways, cerebellar damage can still produce a sensation that closely mimics vestibular dysfunction.

Associated Malignancies

A wide range of cancers have been linked to paraneoplastic cerebellar degeneration. These include small cell lung cancer, ovarian cancer, breast cancer, Hodgkin lymphoma, and tumors of the gastrointestinal tract. In some instances, the neurological syndrome occurs before the underlying malignancy is detected, making the diagnosis particularly challenging.

Distinguishing Cerebellar from Vestibular Dizziness

Evaluating a patient who presents with dizziness requires careful attention to symptom quality. In pure vestibular disorders such as vestibular neuritis or benign paroxysmal positional vertigo, patients often experience acute rotational vertigo accompanied by nausea and vomiting. In contrast, the dizziness associated with paraneoplastic cerebellar degeneration is usually progressive and accompanied by incoordination, speech changes, and oscillopsia, which is the sensation that the environment is jumping.

Clinicians rely on neurological examination, imaging, and laboratory testing to differentiate these entities. Cerebellar signs such as dysmetria and ataxia strongly suggest a central rather than peripheral vestibular origin. In addition, brain magnetic resonance imaging may eventually show atrophy of the cerebellar hemispheres and vermis.

Immunological Markers and Diagnosis

Several autoantibodies have been identified in patients with paraneoplastic cerebellar degeneration, including anti-Yo, anti-Hu, anti-Ri, anti-Tr, and anti-CV2. The presence of these antibodies in serum or cerebrospinal fluid supports the diagnosis. However, some patients may be seronegative, meaning that no known antibody is detected. Definitive diagnosis usually requires a combination of clinical findings, antibody testing, and the identification of an underlying malignancy through imaging such as CT or PET scans.

Treatment Approaches

Treatment of paraneoplastic cerebellar degeneration begins with addressing the underlying cancer. If the tumor is successfully removed, treated with chemotherapy, or controlled with radiation, neurological symptoms may stabilize or, less commonly, improve. Immunotherapy is also used to suppress the autoimmune attack; options include corticosteroids, intravenous immunoglobulin, plasmapheresis, rituximab, and cyclophosphamide.

Despite these interventions, the outcome is often guarded. The majority of patients are left with significant residual ataxia and imbalance because the destroyed Purkinje cells do not regenerate well. Symptomatic management plays an important role. Physical therapy can help patients adapt to their limitations and reduce the risk of falls. Vestibular rehabilitation may be provided to help the nervous system compensate for the combined cerebellar and vestibular challenges the patient faces.

Prognosis and Quality of Life

The prognosis for paraneoplastic cerebellar degeneration is influenced by the type and stage of the underlying cancer, as well as the severity of neurological injury at the time of diagnosis. Early detection of both the disorder and its associated malignancy offers the best chance of preserving function. Patients with paraneoplastic cerebellar degeneration often require multidisciplinary care involving neurologists, oncologists, rehabilitation specialists, and speech-language pathologists.

Living with a chronic disorder characterized by dizziness and imbalance can be extremely challenging. Emotional support, assistive devices such as canes or walkers, and adaptive strategies within the home can improve safety and overall quality of life.

Conclusion

Paraneoplastic cerebellar degeneration is a devastating disorder that illustrates the complex interplay between oncology and neurology. For a patient presenting with unexplained dizziness and progressive incoordination, clinicians should remain vigilant for a paraneoplastic cause. Recognizing the distinction between vestibular and cerebellar origins of imbalance is essential for guiding the diagnostic workup. Although therapeutic options remain limited, early recognition of the condition and prompt screening for occult malignancy are critical steps that may influence both survival and neurological outcome.